Menu
GeneBe

ZNF335

zinc finger protein 335, the group of Zinc fingers C2H2-type

Basic information

Region (hg38): 20:45948659-45972203

Links

ENSG00000198026NCBI:63925OMIM:610827HGNC:15807Uniprot:Q9H4Z2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • microcephalic primordial dwarfism due to ZNF335 deficiency (Strong), mode of inheritance: AR
  • microcephalic primordial dwarfism due to ZNF335 deficiency (Supportive), mode of inheritance: AR
  • microcephalic primordial dwarfism due to ZNF335 deficiency (Moderate), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Microcephaly 10, primary, autosomal recessiveARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic23178126

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ZNF335 gene.

  • not provided (423 variants)
  • Inborn genetic diseases (72 variants)
  • Microcephalic primordial dwarfism due to ZNF335 deficiency (57 variants)
  • not specified (55 variants)
  • Autosomal recessive primary microcephaly (1 variants)
  • ZNF335-related condition (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZNF335 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
86
clinvar
10
clinvar
99
missense
1
clinvar
2
clinvar
214
clinvar
17
clinvar
5
clinvar
239
nonsense
3
clinvar
1
clinvar
1
clinvar
5
start loss
0
frameshift
3
clinvar
3
clinvar
2
clinvar
8
inframe indel
5
clinvar
5
splice donor/acceptor (+/-2bp)
3
clinvar
3
splice region
8
20
7
35
non coding
6
clinvar
46
clinvar
35
clinvar
87
Total 7 8 231 150 50

Highest pathogenic variant AF is 0.0000197

Variants in ZNF335

This is a list of pathogenic ClinVar variants found in the ZNF335 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
20-45948675-C-G Likely benign (Dec 05, 2018)1197755
20-45948675-C-T Benign (Jul 27, 2018)1231704
20-45948956-G-A Likely benign (Nov 27, 2023)1618560
20-45948962-G-A ZNF335-related disorder Likely benign (Feb 02, 2022)1905624
20-45948976-C-T not specified Uncertain significance (Oct 04, 2022)437341
20-45948979-C-T Inborn genetic diseases Uncertain significance (Feb 01, 2023)2467015
20-45948981-T-C Uncertain significance (Sep 27, 2022)1413326
20-45948984-T-C Microcephalic primordial dwarfism due to ZNF335 deficiency Uncertain significance (Mar 02, 2022)453188
20-45948998-C-G Uncertain significance (Mar 20, 2023)2580439
20-45949009-G-C Inborn genetic diseases Uncertain significance (Sep 20, 2022)2369253
20-45949018-C-G Uncertain significance (Jun 02, 2022)1958347
20-45949018-C-T Uncertain significance (Jan 15, 2022)1944965
20-45949019-G-A ZNF335-related disorder Benign/Likely benign (Oct 22, 2023)749252
20-45949030-C-T Uncertain significance (Jun 28, 2022)1379519
20-45949031-G-A Likely benign (Mar 18, 2022)744609
20-45949069-C-T Inborn genetic diseases Uncertain significance (Aug 21, 2023)2620409
20-45949070-A-T Uncertain significance (Jun 20, 2022)2008667
20-45949085-C-T Uncertain significance (Dec 07, 2023)2033668
20-45949163-T-G Likely benign (Jun 13, 2022)1555075
20-45949182-AGT-A Microcephalic primordial dwarfism due to ZNF335 deficiency Uncertain significance (Jan 13, 2021)2438682
20-45949183-G-T Uncertain significance (Dec 02, 2021)1487633
20-45949186-T-C Likely benign (Nov 27, 2023)3018924
20-45949193-G-A Uncertain significance (Aug 23, 2022)2074301
20-45949203-G-A Microcephalic primordial dwarfism due to ZNF335 deficiency Likely benign (Aug 31, 2022)1644616
20-45949213-G-A not specified Likely benign (Dec 29, 2017)1336485

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ZNF335protein_codingprotein_codingENST00000322927 2723542
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
6.89e-71.0012563721091257480.000441
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5507958400.9470.00005298673
Missense in Polyphen280326.90.856523389
Synonymous-0.6323603451.040.00002282771
Loss of Function4.832365.00.3540.00000335710

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006870.000685
Ashkenazi Jewish0.000.00
East Asian0.0005440.000544
Finnish0.0004350.000416
European (Non-Finnish)0.0005460.000501
Middle Eastern0.0005440.000544
South Asian0.0003000.000294
Other0.001150.00114

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component or associated component of some histone methyltransferase complexes may regulate transcription through recruitment of those complexes on gene promoters. Enhances ligand- dependent transcriptional activation by nuclear hormone receptors. Plays an important role in neural progenitor cell proliferation and self-renewal through the regulation of specific genes involved brain development, including REST. Also controls the expression of genes involved in somatic development and regulates, for instance, lymphoblast proliferation. {ECO:0000269|PubMed:12215545, ECO:0000269|PubMed:18180299, ECO:0000269|PubMed:23178126}.;
Disease
DISEASE: Microcephaly 10, primary, autosomal recessive (MCPH10) [MIM:615095]: A form of microcephaly, a disease defined as a head circumference more than 3 standard deviations below the age- related mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. MCPH10 is characterized by extremely small head size and death usually by 1 year of age. Neuropathologic examination shows severe loss of neurons as well as neuronal loss of polarity and abnormal dendritic maturation. {ECO:0000269|PubMed:23178126}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.103

Intolerance Scores

loftool
0.625
rvis_EVS
-1.12
rvis_percentile_EVS
6.62

Haploinsufficiency Scores

pHI
0.321
hipred
N
hipred_score
0.476
ghis
0.619

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
S
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.972

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Zfp335
Phenotype
hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);

Gene ontology

Biological process
in utero embryonic development;positive regulation of neuroblast proliferation;regulation of transcription by RNA polymerase II;brain development;regulation of gene expression;cerebral cortex neuron differentiation;regulation of gene expression, epigenetic;neuron projection morphogenesis;brain morphogenesis;positive regulation of lymphocyte proliferation;positive regulation of neurogenesis;regulation of histone H3-K4 methylation;histone H3-K4 trimethylation
Cellular component
nucleus;nucleoplasm;histone methyltransferase complex
Molecular function
RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II core promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;protein binding;transcription regulatory region DNA binding;metal ion binding